Navigation Links
SaltCheck Develops First Simplified Test for Monitoring Salt Intake in People With Hypertension
Date:2/26/2009

BOSTON, Feb. 26 /PRNewswire/ -- SaltCheck, Inc. announced the completion of a 100 subject study demonstrating successful use of a new simplified test for monitoring sodium intake. The test, which can be used either for self-monitoring by people with hypertension, or for point-of-care testing at the physician's office, is revolutionary in providing immediate feedback on urine sodium excretion, which closely mirrors sodium intake. It involves dipstick testing, with results refined by statistical adjustments derived from a series of clinical studies.

The World Health Organization estimates there are over 600 million people globally with hypertension, and salt intake is known to affect blood pressure and/or response to blood pressure medication in most. Awareness of salt intake, and efforts to reduce salt intake are receiving increasing emphasis. The National Institutes of Health has recommended limiting intake of salt upon diagnosis of hypertension.

The studies, which were conducted at Weill Cornell Medical College, and sponsored by SaltCheck, Inc., accurately estimated sodium excretion from a simple spot check of urine. The SaltCheck test provides a snapshot of the state of sodium excretion, and also correctly indicates whether a patient's sodium excretion over a 24-hour period is low or not, with a high degree of sensitivity and specificity. Most important, it will be the first commercially-available test for assessing salt intake, and its ease of use and low cost will readily enable serial monitoring of salt intake, and of the effect of efforts to change salt intake.

The test also eliminates the two biggest drawbacks of the current testing method, which consists of collecting all urine during a 24 hour period, and sending it to a laboratory. "The standard test is frequently inaccurate because of incomplete collections, reflecting the difficulty and impracticality of collecting all urine for 24 hours. Worse, because the test is so cumbersome, very few doctors and patients ever evaluate salt intake, despite the growing and widespread awareness of its importance in managing hypertension," commented Marc Eichenberger, COO of Allied Minds, the parent company of SaltCheck.

Owing to its ease of use, suitability for serial monitoring, and accuracy of results, SaltCheck has the potential to help in the management of many millions with hypertension. Surveys suggest that physicians would embrace testing of their patients' salt intake if a convenient and inexpensive test were available. Testing could also help improve patient compliance with drug and dietary prescriptions.

"We are extremely pleased with the results from this significant study and the commercial progress to-date of the company. We very much look forward to bringing this groundbreaking test to the market to help patients and doctors worldwide in managing hypertension," added Mr. Eichenberger.

About SaltCheck, Inc. and Allied Minds, Inc.

SaltCheck is a privately-held startup company formed by Allied Minds, Inc. to commercialize a groundbreaking patient salt intake monitoring system that doesn't require laboratory facilities. The technology was originally developed at Weill Cornell Medical College by Drs. Samuel Mann and Linda Gerber, who conducted the studies reported here. For more information, please visit the SaltCheck website: www.saltcheck.com.

Allied Minds, Inc. is the premier seed organization for early-stage technology. The company focuses on converting academic discoveries into commercial reality by working exclusively with a network of U.S. universities and national labs. By filling the gap between government grants and traditional venture capitalists, Allied Minds focuses on funding innovations with significant transformative potential. Instead of managing funds, the company fosters early-stage companies through to success, generating value for all stakeholders. Allied Minds has a nationwide footprint with offices in Boston, Seattle, Washington, D.C. and Los Angeles, and a European presence in London, United Kingdom. Website: www.alliedminds.com

Disclosure

Weill Cornell Medical College requires their faculty members Drs Mann and Gerber to disclose that they and Weill Cornell Medical College have a potential financial interest in the outcome of this study.


'/>"/>
SOURCE SaltCheck, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Couples more likely to divorce if spouse develops cervical or testicular cancer
2. Corey McPherson Nash Develops Case Statement for Dana-Farber Cancer Institute Capital Campaign
3. UCLA doctor develops new technique to treat varicose veins
4. Biomarkers predict risk for invasive breast cancer years before the tumor develops
5. Silverchair Learning Systems Updates and Develops New Courses
6. OHSU Cancer Institute researcher develops test for targeted therapy in acute myeloid leukemia
7. Capsulated Systems, Inc. Develops Long Term Local Anesthetic
8. MIT develops thin-film micro pharmacy
9. Omron Healthcare Develops Solar-Powered Digital Blood Pressure Monitors
10. Psychologist develops post-operative care for heart patients in Bermuda
11. Medical Records Institute (MRI) Develops Initiative for EMRs Supporting Medicolegal Requirements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & Wellness ... Moonlight to raise money for the American Heart Association Heart Walk. Teams of up ... work together to keep their treadmills moving for 5 hours. Treadmills will start at ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United States, single-family ... some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average ... extremely low property-tax rates, which contributes to the relatively lower cost of living ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , Sept. ... Penn. , and OptiMed Specialty Pharmacy of ... partnership to offer a strategic hub service that expedites ... highly sought-after personal spirometer, Spiro PD 2.0, and wellness ... A spirometer is a medical device used to measure ...
(Date:9/13/2017)... , Sept. 13, 2017   OrthoAtlanta has ... the Atlanta Football Host Committee (AFHC) for the 2018 College ... Jan. 8, 2018, at Mercedes-Benz Stadium in Atlanta, ... of the AFHC "I,m In" campaign, participating in many activities ... ...
Breaking Medicine Technology: